Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Istodax Gets FDA Approval
The FDA has approved Istodax (romidepsin), an injectable medication, for treatment of patients with cutaneous T-cell lymphoma (CTCL). Istodax interferes with processes required for cell replication. It is
The FDA has approved Istodax (romidepsin), an injectable medication, for treatment of patients with cutaneous T-cell lymphoma (CTCL). Istodax interferes with processes required for cell replication. It is
Harro Hofliger has introduced a fully automatic production of inhalation blisters. This powder-in-blister platform is designed for clinical testing, small-series production of inhalation preparations. The company said that
Compugen has reported the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes. The company said that the new biomarker was discovered
Harro Hofliger has introduced OmniControl, which is a modular checking system for maximum flexibility with the weighing of solida. The company said that OmniControl is the format-free checking
Zosano Pharma has revealed results from a positive Phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis. The results were published in
AnaSpec has enhanced its SensoLyte pNPP Alkaline Phosphatase Assay kits with the addition of a specially formulated pNPP substrate. According to AnaSpec the new substrate advantages include, ready
Daiichi Sankyo has brought a lawsuit before the Intellectual Property High Court to have the decision to nullify a portion of the patent term extension for Levofloxacin Hydrate
GlaxoSmithKline (GSK) has reported the results from the clinical trial assessing Pandemrix. GSK’s adjuvanted H1N1 pandemic influenza vaccine, Pandemrix is administered at the same time as the annual
Bayer MaterialScience (Bayer) has expanded the capacity of Desmodur N aliphatic coatings raw materials at its integrated site in Caojing, near Shanghai in China. The company said that
The US Department of Health and Human Services (HHS) has reported the contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat